Get the Stockscreener App
8.86
1.12%
-0.10
After Hours:
8.69
-0.17
-1.92%
Angiodynamic Inc stock is traded at $8.86, with a volume of 440.19K.
It is down -1.12% in the last 24 hours and down -10.69% over the past month.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
See More
Previous Close:
$8.96
Open:
$8.83
24h Volume:
440.19K
Relative Volume:
0.70
Market Cap:
$360.02M
Revenue:
$324.01M
Net Income/Loss:
$-192.37M
P/E Ratio:
-1.8536
EPS:
-4.78
Net Cash Flow:
$-23.46M
1W Performance:
-2.74%
1M Performance:
-10.69%
6M Performance:
-22.35%
1Y Performance:
+13.01%
1-Day Range:
$8.7269
$8.9098
1-Week Range:
$8.7269
$9.32
52-Week Range:
$5.83
$13.50
Angiodynamic Inc Stock (ANGO) Company Profile
Name
Angiodynamic Inc
Sector
Industry
Phone
(518) 798-1215
Address
14 PLAZA DRIVE, LATHAM
Compare ANGO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANGO
Angiodynamic Inc
|
8.86 | 364.08M | 324.01M | -192.37M | -23.46M | -4.78 |
|
ISRG
Intuitive Surgical Inc
|
481.09 | 179.42B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
178.25 | 52.03B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.55 | 44.11B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
271.94 | 40.68B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
239.26 | 17.92B | 2.90B | 467.20M | 306.90M | 6.37 |
Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-16-25 | Initiated | Lake Street | Buy |
| Apr-05-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Sep-25-23 | Initiated | H.C. Wainwright | Buy |
| Apr-17-23 | Downgrade | Raymond James | Strong Buy → Outperform |
| Oct-15-21 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-20-21 | Initiated | Oppenheimer | Perform |
| Nov-25-20 | Upgrade | Raymond James | Mkt Perform → Strong Buy |
| Apr-08-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-01-19 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-03-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-05-18 | Downgrade | Craig Hallum | Buy → Hold |
| Apr-07-17 | Reiterated | Cantor Fitzgerald | Overweight |
| Mar-30-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
| Feb-08-17 | Initiated | Barclays | Equal Weight |
| Nov-04-16 | Initiated | Cantor Fitzgerald | Buy |
| Apr-08-16 | Resumed | Piper Jaffray | Neutral |
| Jan-08-16 | Reiterated | Canaccord Genuity | Buy |
| Nov-10-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-24-15 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jun-19-14 | Upgrade | Canaccord Genuity | Hold → Buy |
| Oct-09-12 | Reiterated | Canaccord Genuity | Hold |
| Jun-25-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jul-15-11 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jul-15-11 | Upgrade | Stifel Nicolaus | Hold → Buy |
| Jun-14-11 | Downgrade | Wedbush | Neutral → Underperform |
| Sep-08-10 | Reiterated | Wedbush | Neutral |
View All
Angiodynamic Inc Stock (ANGO) Latest News
AngioDynamics Inc. stock retracement – recovery analysisConsistent Gain Plan with AI Support - Newser
How does AngioDynamics Inc. compare to its industry peersFinancial News Planner For Beginners - jammulinksnews.com
22,671 Shares in AngioDynamics, Inc. (NASDAQ:ANGO) Bought by Y Intercept Hong Kong Ltd - Defense World
Regression analysis insights on AngioDynamics Inc. performanceGrowth Projection Summary for Long-Term Investors - Newser
What makes AngioDynamics Inc. stock price move sharplyLow Risk Guidance That Work - jammulinksnews.com
AngioDynamics Inc. Recovery Likely Here’s What Data ShowsWeekly Watchlist of High Movers Released - metal.it
What institutional investors are buying AngioDynamics Inc. stockMaximize your portfolio’s earning power - jammulinksnews.com
Is AngioDynamics Inc. stock overvalued or undervaluedPost Market Outlook For Every Investor - jammulinksnews.com
Building trade automation scripts for AngioDynamics Inc.Free Community Shared Smart Money Signals - Newser
How strong is AngioDynamics Inc. company’s balance sheetUnlock powerful investment tools for free - jammulinksnews.com
Is AngioDynamics Inc. a growth stock or a value stockUnprecedented profit potential - jammulinksnews.com
When is AngioDynamics Inc. stock expected to show significant growthMaximize returns with data-driven strategies - jammulinksnews.com
What is AngioDynamics Inc. company’s growth strategyOver 200% growth - jammulinksnews.com
How AngioDynamics Inc. stock performs during market volatilityFree High Yield Stocks With Buy Confirmation - Newser
Why AngioDynamics Inc. stock attracts strong analyst attentionEntry Level Low Risk Picks - Newser
New York State Common Retirement Fund Has $513,000 Stock Holdings in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
What drives AngioDynamics Inc. stock priceUnstoppable profit momentum - PrintWeekIndia
Is AngioDynamics Inc. a good long term investmentOutstanding capital returns - PrintWeekIndia
What analysts say about AngioDynamics Inc. stockFree AI-Backed Trading Signals - Autocar Professional
AngioDynamics Inc. Stock Analysis and ForecastMarket-beating performance - Autocar Professional
Principal Financial Group Inc. Raises Stock Position in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
AngioDynamics (NASDAQ:ANGO) Given a $17.00 Price Target at Canaccord Genuity Group - Defense World
HC Wainwright Reiterates Buy Rating for AngioDynamics (NASDAQ:ANGO) - Defense World
AngioDynamics Reports Strong Growth in Fiscal 2025 - The Globe and Mail
AngioDynamics, Inc. (NASDAQ:ANGO) EBITDA Improves - FXDailyReport.Com
AngioDynamics, Inc. (NASDAQ:ANGO) Q4 2025 Earnings Call Transcript - Insider Monkey
AngioDynamics Inc (ANGO) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Tariff ... - Yahoo Finance
AngioDynamics Reports Strong Growth Amid Challenges - TipRanks
Angiodynamic Inc Stock (ANGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.22%
22.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):